MedPath

MINT-PRAVASTATIN

MINT-PRAVASTATIN

Approved
DIN Number

02317451

Drug Class

Human

Market Date

Feb 6, 2009

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02317451
AIG Number0122563001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AA03 PRAVASTATIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

PRAVASTATIN SODIUMActive
Strength: 10 MG
Monograph: PRAVASTATIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.